-
The global research community requires the correct research of COVID-19 in the right place.
Time of Update: 2020-07-28
NEW YEAR-OLD - A report has been released calling for the use of research evidence on the best implementation of public health interventions in different global settings In the absence of vaccines and
-
Psoriasis Phase III Clinical: Lilly's IL-23 Monoantimizumab is better than Novartis's IL-17A Monotstyx.
Time of Update: 2020-07-28
Lilly incision () monoantitherapy patients with primary to severe plaque-like psoriasis showed that the drug reached all major and major secondary endpoints in the first week compared to a placebo And
-
New achievements made by scientists in the field of organ transplantation!
Time of Update: 2020-07-28
"This article collates the recent achievements made by scientists in the field of organ transplantation research to learn with you! FILE Photo: A new technology has been developed that can significan
-
How to develop a universal vaccine that beats COVID, SARS, MERS and the common cold!
Time of Update: 2020-07-28
"New Year's Day " - The virus that causes it belongs to a family of coronaviruses that can cause everything from the common cold to MERS, which kills about one-third of those infected Although these
-
First lupus nephritis (LN) drug! The new best-in-class calcium-modulating neurophosphatase inhibitor voclosporin has been reviewed by the FDA!
Time of Update: 2020-07-28
New Year's Day is a biopharmaceutical company dedicated to the development of innovative therapies for kidney disease and autoimmune diseases The company recently announced that the U.S Food and Drug
-
NEJM: PRIME cells with rheumatoid arthritis attacks.
Time of Update: 2020-07-28
Rheumatoid arthritis, like many inflammatory diseases, has a period of rest and deterioration (flare) but the mechanism that causes the flare is not clear Recently, researchers established a clinical
-
Clin Cancer Res: Scientists have identified new potential targets for immunotherapy for melanoma.
Time of Update: 2020-07-28
A recent study published in the International Journal of the Institute of Medicine and other scientists through a study revealed why some melanoma patients do not respond to immunotherapy related find
-
Science: Three different immune responses were revealed in patients with more severe COVID-19.
Time of Update: 2020-07-28
In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania found that three different immune responses to infections may help predict the trajectory of disease i
-
A new drug for adhesion dermatitis (AD) ! AbbVie oral JAK inhibitor Rinvoq single drug treatment of severe AD Phase II PHASE III STUDY WAS SUCCESSFUL!
Time of Update: 2020-07-28
AbbVie () recently announced that the evaluation of oral inhibitors () single drug therapy for aspecific dermatitis () phase II clinical study ( ) has reached the primary and all secondary endpoints T
-
The interleukin-1 blocker Rilonacept treats operitis and is awarded the title of orphan drug by the FDA.
Time of Update: 2020-07-28
The company announced that the treatment of encephalomyelitis, including recurrent encephalitis, has been awarded the title of Orphan Drug by the U.S Food and Drug Administration () Recombinant fusio
-
Several important research results focus on new advances in microRNA molecular research!
Time of Update: 2020-07-28
"This article has compiled a number of important research results to focus on scientists in the field of molecular research and new progress to share with you! Photo Source: : New Breakthrough! Scien
-
Science: Uncovering how metastatic cancer keeps moving in an unfavourable cobweb subcavity environment?
Time of Update: 2020-07-28
In a recent study published in the international journal, scientists from institutions such as memorial Sloan Kettering Cancer Center have revealed how metastatic cancer survives in an adverse cobweb
-
Nature's big break! Create a complete sequence of human X chromosomes!
Time of Update: 2020-07-28
Researchers at the National Human Genome Institute, part of the National Institutes of Health, created the first end-to-end sequence of human chromosomes The results, published recently in the journa
-
NEJM: Local therapy of loferst cream can significantly improve skin symptoms in psoriasis patients.
Time of Update: 2020-07-28
Oral systemic phosphodiesterase inhibitors have a better efficacy in the treatment of psoriasis Recently researchers assessed the effectiveness of local treatment of psoriasis in Loforstette cream Adu
-
Several articles focus on important research results in the field of atherosclerosis research!
Time of Update: 2020-07-28
"This article has compiled a number of important research results to focus on recent advances in the field of atherosclerosis research to share with you! FILE Photo: Revealing the relationship betwee
-
Systemic sclerosis-related interstitial pulmonary disease patients, how to turn the risk of "dimensional" yi?
Time of Update: 2020-07-28
the results showed that compared with placebo, nidanib significantly reduced the annual decline rate of FVC in SSc ILD patients and delayed disease progression.
-
Arthritis pain "death to live", these methods are too useful! Guide time.
Time of Update: 2020-07-28
the guidelines for non-surgical treatment of osteoarthritis published by OARSI in 2019 strongly recommend topical NSAIDs for patients with knee OA, especially for patients with gastrointestinal and / or cardiovascular diseases, as well as elderly and frail patients.
-
Wound healing itch treatment is expected, Immunity posted that IL-31 is the culprit!
Time of Update: 2020-07-28
Image Source: immunity in this study, researchers found that in the process of skin wound healing, cdc2s enhanced the sensitivity of sensory neurons through the TGF - β - IL-31 axis, leading to the occurrence of wound itching.
-
Progress has been made in the study of the mechanism of regulation of oyster blood lymphatic swallowing.
Time of Update: 2020-07-28
The Research Team on Marine Biomolecular Biology and Genetics of Marine Biomolecular Biology and Ecology at the South China Sea Marine Research Institute of the Chinese Academy of Sciences has been en
-
Mol Cell Biol: A glitch in DNA replication in cells may hopefully help develop new treatments for cancer.
Time of Update: 2020-07-28
In a recent study published in the international journal, scientists from the University of Southern California and others have conducted in-depth studies of living cells to find that the special syst
